Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients
Copyright © 2023 Elsevier Inc. All rights reserved..
Antibodies effective against the recent Omicron sublineages are missing. By taking advantage of a multi-centric prospective cohort of immunocompromised individuals treated for mild-to-moderate COVID-19, Bruel et al. show that administration of 500 mg of sotrovimab induces serum neutralization and antibody-dependent cellular cytotoxicity of BQ.1.1 and XBB.1.5. Therefore, sotrovimab may remain a therapeutic option against these variants.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
---|---|
Enthalten in: |
Med (New York, N.Y.) - 4(2023), 10 vom: 13. Okt., Seite 664-667 |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
1MTK0BPN8V |
---|
Anmerkungen: |
Date Completed 01.11.2023 Date Revised 30.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1016/j.medj.2023.07.007 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363309225 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363309225 | ||
003 | DE-627 | ||
005 | 20240331000716.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.medj.2023.07.007 |2 doi | |
028 | 5 | 2 | |a pubmed24n1357.xml |
035 | |a (DE-627)NLM363309225 | ||
035 | |a (NLM)37837962 | ||
035 | |a (PII)S2666-6340(23)00230-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bruel, Timothée |e verfasserin |4 aut | |
245 | 1 | 0 | |a Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.11.2023 | ||
500 | |a Date Revised 30.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
520 | |a Antibodies effective against the recent Omicron sublineages are missing. By taking advantage of a multi-centric prospective cohort of immunocompromised individuals treated for mild-to-moderate COVID-19, Bruel et al. show that administration of 500 mg of sotrovimab induces serum neutralization and antibody-dependent cellular cytotoxicity of BQ.1.1 and XBB.1.5. Therefore, sotrovimab may remain a therapeutic option against these variants | ||
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a sotrovimab |2 NLM | |
650 | 7 | |a 1MTK0BPN8V |2 NLM | |
650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
650 | 7 | |a Antiviral Agents |2 NLM | |
700 | 1 | |a Vrignaud, Lou-Léna |e verfasserin |4 aut | |
700 | 1 | |a Porrot, Françoise |e verfasserin |4 aut | |
700 | 1 | |a Staropoli, Isabelle |e verfasserin |4 aut | |
700 | 1 | |a Planas, Delphine |e verfasserin |4 aut | |
700 | 1 | |a Guivel-Benhassine, Florence |e verfasserin |4 aut | |
700 | 1 | |a Puech, Julien |e verfasserin |4 aut | |
700 | 1 | |a Prot, Matthieu |e verfasserin |4 aut | |
700 | 1 | |a Munier, Sandie |e verfasserin |4 aut | |
700 | 1 | |a Bolland, William Henry |e verfasserin |4 aut | |
700 | 1 | |a Soulié, Cathia |e verfasserin |4 aut | |
700 | 1 | |a Zafilaza, Karen |e verfasserin |4 aut | |
700 | 1 | |a Lusivika-Nzinga, Clovis |e verfasserin |4 aut | |
700 | 1 | |a Meledge, Marie-Laure |e verfasserin |4 aut | |
700 | 1 | |a Dorival, Céline |e verfasserin |4 aut | |
700 | 1 | |a Molino, Diana |e verfasserin |4 aut | |
700 | 1 | |a Péré, Hélène |e verfasserin |4 aut | |
700 | 1 | |a Yordanov, Youri |e verfasserin |4 aut | |
700 | 1 | |a Simon-Lorière, Etienne |e verfasserin |4 aut | |
700 | 1 | |a Veyer, David |e verfasserin |4 aut | |
700 | 1 | |a Carrat, Fabrice |e verfasserin |4 aut | |
700 | 1 | |a Schwartz, Olivier |e verfasserin |4 aut | |
700 | 1 | |a Marcelin, Anne-Geneviève |e verfasserin |4 aut | |
700 | 1 | |a Martin-Blondel, Guillaume |e verfasserin |4 aut | |
700 | 0 | |a ANRS 0003S CoCoPrev Study Group |e verfasserin |4 aut | |
700 | 1 | |a Garcia, Magalie |e investigator |4 oth | |
700 | 1 | |a Giraud, Valentin |e investigator |4 oth | |
700 | 1 | |a Metais, Agathe |e investigator |4 oth | |
700 | 1 | |a Cazenave-Roblot, Fance |e investigator |4 oth | |
700 | 1 | |a Martellosio Anne-Marie Ronchetti, Jean-Philippe |e investigator |4 oth | |
700 | 1 | |a Gabas, Thomas |e investigator |4 oth | |
700 | 1 | |a Hadjadj, Naima |e investigator |4 oth | |
700 | 1 | |a Salanoubat, Célia |e investigator |4 oth | |
700 | 1 | |a Chabrol, Amélie |e investigator |4 oth | |
700 | 1 | |a Housset, Pierre |e investigator |4 oth | |
700 | 1 | |a Pardon, Agathe |e investigator |4 oth | |
700 | 1 | |a Faucon, Anne-Laure |e investigator |4 oth | |
700 | 1 | |a Caudwell, Valérie |e investigator |4 oth | |
700 | 1 | |a Roland Liblau, Latifa Hanafi |e investigator |4 oth | |
700 | 1 | |a Alric, Laurent |e investigator |4 oth | |
700 | 1 | |a Pugnet, Grégory |e investigator |4 oth | |
700 | 1 | |a Mourguet, Morgane |e investigator |4 oth | |
700 | 1 | |a Bories, Eva |e investigator |4 oth | |
700 | 1 | |a Bonnet, Delphine |e investigator |4 oth | |
700 | 1 | |a Charpentier, Sandrine |e investigator |4 oth | |
700 | 1 | |a Delobel, Pierre |e investigator |4 oth | |
700 | 1 | |a Debard, Alexa |e investigator |4 oth | |
700 | 1 | |a Beck, Colleen |e investigator |4 oth | |
700 | 1 | |a Boumaza, Xavier |e investigator |4 oth | |
700 | 1 | |a Fanny Lanternier, Stella Rousset |e investigator |4 oth | |
700 | 1 | |a Delage, Claire |e investigator |4 oth | |
700 | 1 | |a Pires, Elisabete Gomes |e investigator |4 oth | |
700 | 1 | |a Cheminant, Morgane |e investigator |4 oth | |
700 | 1 | |a Anthony Chauvin, Nathalie Chavarot |e investigator |4 oth | |
700 | 1 | |a Véronique Delcey Simon Bessis, Xavier Eyer |e investigator |4 oth | |
700 | 1 | |a Cresta, Mélanie |e investigator |4 oth | |
700 | 1 | |a Pélagie Thibaut, Romain Gueneau |e investigator |4 oth | |
700 | 1 | |a Nadal, Marine |e investigator |4 oth | |
700 | 1 | |a Siguier, Martin |e investigator |4 oth | |
700 | 1 | |a Bachir, Marwa |e investigator |4 oth | |
700 | 1 | |a Valérie Pourcher, Christia Palacios |e investigator |4 oth | |
700 | 1 | |a Melenotte, Cléa |e investigator |4 oth | |
700 | 1 | |a Faycal, Antoine |e investigator |4 oth | |
700 | 1 | |a Berot, Vincent |e investigator |4 oth | |
700 | 1 | |a Brin, Cécile |e investigator |4 oth | |
700 | 1 | |a Djebara, Siham |e investigator |4 oth | |
700 | 1 | |a Zafilaza, Karen |e investigator |4 oth | |
700 | 1 | |a Marot, Stéphane |e investigator |4 oth | |
700 | 1 | |a Sayon, Sophie |e investigator |4 oth | |
700 | 1 | |a Leducq, Vincent |e investigator |4 oth | |
700 | 1 | |a Malet, Isabelle |e investigator |4 oth | |
700 | 1 | |a Teyssou, Elisa |e investigator |4 oth | |
700 | 1 | |a Karine Lacombe, Adélie Gothland |e investigator |4 oth | |
700 | 1 | |a Aad, Yasmine Abi |e investigator |4 oth | |
700 | 1 | |a Chiarabini, Thibault |e investigator |4 oth | |
700 | 1 | |a Feliho, Raynald |e investigator |4 oth | |
700 | 1 | |a Valin, Nadia |e investigator |4 oth | |
700 | 1 | |a Brigant, Fabien |e investigator |4 oth | |
700 | 1 | |a Boize, Julien |e investigator |4 oth | |
700 | 1 | |a Thiébaud, Pierre-Clément |e investigator |4 oth | |
700 | 1 | |a Moreau, Marie |e investigator |4 oth | |
700 | 1 | |a Nathalie De Castro, Charlotte Billard |e investigator |4 oth | |
700 | 1 | |a Liégeon, Geoffroy |e investigator |4 oth | |
700 | 1 | |a Denis, Blandine |e investigator |4 oth | |
700 | 1 | |a Molina, Jean-Michel |e investigator |4 oth | |
700 | 1 | |a André Cabié, Lucia Etheve |e investigator |4 oth | |
700 | 1 | |a Abel, Sylvie |e investigator |4 oth | |
700 | 1 | |a Cabras, Ornella |e investigator |4 oth | |
700 | 1 | |a Guitteaud, Karine |e investigator |4 oth | |
700 | 1 | |a François Vincent Dubee, Sandrine Pierre- |e investigator |4 oth | |
700 | 1 | |a Ndiaye, Diama |e investigator |4 oth | |
700 | 1 | |a Pehlivan, Jonathan |e investigator |4 oth | |
700 | 1 | |a Phelippeau, Michael |e investigator |4 oth | |
700 | 1 | |a Alexandre Duvignaud, Rafael Mahieu |e investigator |4 oth | |
700 | 1 | |a Pistone, Thierry |e investigator |4 oth | |
700 | 1 | |a Desclaux, Arnaud |e investigator |4 oth | |
700 | 1 | |a Neau, Didier |e investigator |4 oth | |
700 | 1 | |a Jean-François Faucher, Charles Cazanave |e investigator |4 oth | |
700 | 1 | |a Festou, Benjamin |e investigator |4 oth | |
700 | 1 | |a Dupuy-Grasset, Magali |e investigator |4 oth | |
700 | 1 | |a Loustaud-Ratti, Véronique |e investigator |4 oth | |
700 | 1 | |a Nathan Peiffer-Smadja, Delphine Chainier |e investigator |4 oth | |
700 | 1 | |a Choquet, Christophe |e investigator |4 oth | |
700 | 1 | |a Da Conceicao, Olivia |e investigator |4 oth | |
700 | 1 | |a Thy, Michael |e investigator |4 oth | |
700 | 1 | |a Collas, Lio |e investigator |4 oth | |
700 | 1 | |a Godard, Cindy |e investigator |4 oth | |
700 | 1 | |a Bouzid, Donia |e investigator |4 oth | |
700 | 1 | |a Ing, Vittiaroat |e investigator |4 oth | |
700 | 1 | |a Pereira, Laurent |e investigator |4 oth | |
700 | 1 | |a Pavlowsky, Thomas |e investigator |4 oth | |
700 | 1 | |a RavautAntoine Asquier-Khati, Camille |e investigator |4 oth | |
700 | 1 | |a Boutoille, David |e investigator |4 oth | |
700 | 1 | |a Chauveau, Marie |e investigator |4 oth | |
700 | 1 | |a Deschanvres, Colin |e investigator |4 oth | |
700 | 1 | |a Audrey Le Bot, François Raffi |e investigator |4 oth | |
700 | 1 | |a Cailleaux, Marine |e investigator |4 oth | |
700 | 1 | |a Benezit, François |e investigator |4 oth | |
700 | 1 | |a Maillard, Anne |e investigator |4 oth | |
700 | 1 | |a Hue, Benoit |e investigator |4 oth | |
700 | 1 | |a François Coustilleres, Pierre Tattevin |e investigator |4 oth | |
700 | 1 | |a Carvalho-Schneider, Claudia |e investigator |4 oth | |
700 | 1 | |a Jamard, Simon |e investigator |4 oth | |
700 | 1 | |a Petit, Laeticia |e investigator |4 oth | |
700 | 1 | |a Natacha Mrozek, Karl Stefic |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Med (New York, N.Y.) |d 2020 |g 4(2023), 10 vom: 13. Okt., Seite 664-667 |w (DE-627)NLM314117954 |x 2666-6340 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:2023 |g number:10 |g day:13 |g month:10 |g pages:664-667 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.medj.2023.07.007 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 4 |j 2023 |e 10 |b 13 |c 10 |h 664-667 |